FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2906750861> ?p ?o ?g. }

• W2906750861 endingPage "217" @default.
• W2906750861 startingPage "203" @default.
• W2906750861 abstract "Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a life-threatening condition of critically-ill patients, characterized by overwhelming inflammatory responses in the lung. Multiple lines of evidence suggest that the excessive activation of Toll-like receptor 4 (TLR4) plays an important role in this detrimental lung inflammation. Recently, we developed a unique class of peptide-gold nanoparticle (GNP) hybrids that act as potent nano-inhibitors of TLR4 signaling by modulating the process of endosomal acidification. In this study, we aimed to identify the key physiochemical factors that could further strengthen the anti-inflammatory activity of these nano-inhibitors, including the nanoparticle size, the density of peptides coating the nanoparticle surface, as well as the number of the effective amino acid phenylalanine (F) residues in the peptide sequence. Among these factors, we found that the nanoparticle size could significantly affect the TLR4 inhibition. Specifically, the peptide-GNP hybrids with a GNP core of 20 nm (P12(G20)) exhibited the most potent inhibitory activity on TLR4 activation and its downstream cytokine production among those with a GNP core of 13 nm (P12(G13)) and 5 nm (P12(G5)) in THP-1 cell-derived macrophages. This size-dependent anti-inflammatory effect of the hybrid P12 was also observed in a lipopolysaccharide (LPS)-induced mouse model of ALI. It was found that P12(G20) was superior to P12(G13) in prolonging the survival of mice experiencing lethal LPS challenge, decreasing the acute lung inflammation, and alleviating diffuse alveolar damage in the lungs. Interestingly, P12(G20) could also promote long-term tolerance to endotoxin. Detailed mechanistic studies demonstrated that when compared to the smaller P12(G13), the larger P12(G20) had higher cellular uptake and a stronger endosomal pH buffering capacity, contributing to its enhanced therapeutic effects on reducing TLR4 activation in vitro and in vivo. Overall, this study suggests that nanoparticle size is one key factor determining the anti-inflammatory potency of the peptide-GNP hybrids, and the hybrid P12 may serve as a promising, novel class of nanotherapeutics for modulating TLR signaling to treat ALI/ARDS. STATEMENT OF SIGNIFICANCE: We have developed a new class of nanoparticle-based inhibitors (i.e., peptide-GNP hybrids) targeting TLR4 signaling in macrophages. Through evidence-based engineering of the nanoparticle size, surface peptide ligand density and effective amino acid (phenylalanine, F) chain length, we identified a peptide-GNP hybrid, P12(G20), with enhanced anti-inflammatory activity. Specifically, P12(G20) was more potent in reducing inflammation in THP-1 cell-derived macrophages and in a LPS-induced ALI mouse model. More interestingly, P12(G20) facilitated long-term protection against lethal LPS challenge in vivo and induced endotoxin tolerance in vitro. We anticipate that these new hybrids would serve as the next generation anti-inflammatory nano-therapeutics for the treatment of ALI/ARDS or other acute and chronic inflammatory diseases." @default.
• W2906750861 created "2019-01-11" @default.
• W2906750861 creator A5003576716 @default.
• W2906750861 creator A5009887300 @default.
• W2906750861 creator A5014598829 @default.
• W2906750861 creator A5029484872 @default.
• W2906750861 creator A5030691366 @default.
• W2906750861 creator A5034127714 @default.
• W2906750861 creator A5040540554 @default.
• W2906750861 creator A5069771802 @default.
• W2906750861 creator A5071212252 @default.
• W2906750861 creator A5071892654 @default.
• W2906750861 date "2019-02-01" @default.
• W2906750861 modified "2023-10-13" @default.
• W2906750861 title "Size-dependent anti-inflammatory activity of a peptide-gold nanoparticle hybrid in vitro and in a mouse model of acute lung injury" @default.
• W2906750861 cites W1566201062 @default.
• W2906750861 cites W1600560134 @default.
• W2906750861 cites W1649418318 @default.
• W2906750861 cites W1832918390 @default.
• W2906750861 cites W1973078202 @default.
• W2906750861 cites W1977125458 @default.
• W2906750861 cites W1980513483 @default.
• W2906750861 cites W1988296387 @default.
• W2906750861 cites W1989222262 @default.
• W2906750861 cites W1990819855 @default.
• W2906750861 cites W1993197717 @default.
• W2906750861 cites W1997255681 @default.
• W2906750861 cites W2019560197 @default.
• W2906750861 cites W2020753889 @default.
• W2906750861 cites W2029045497 @default.
• W2906750861 cites W2034218807 @default.
• W2906750861 cites W2044780100 @default.
• W2906750861 cites W2047334004 @default.
• W2906750861 cites W2050027509 @default.
• W2906750861 cites W2050413576 @default.
• W2906750861 cites W2054471123 @default.
• W2906750861 cites W2061360993 @default.
• W2906750861 cites W2062757127 @default.
• W2906750861 cites W2063741056 @default.
• W2906750861 cites W2065423690 @default.
• W2906750861 cites W2068854215 @default.
• W2906750861 cites W2071636590 @default.
• W2906750861 cites W2073726484 @default.
• W2906750861 cites W2074935456 @default.
• W2906750861 cites W2075832148 @default.
• W2906750861 cites W2075860675 @default.
• W2906750861 cites W2087906216 @default.
• W2906750861 cites W2092509739 @default.
• W2906750861 cites W2095970309 @default.
• W2906750861 cites W2104630342 @default.
• W2906750861 cites W2107756640 @default.
• W2906750861 cites W2108615682 @default.
• W2906750861 cites W2111428445 @default.
• W2906750861 cites W2111635789 @default.
• W2906750861 cites W2145865499 @default.
• W2906750861 cites W2148281700 @default.
• W2906750861 cites W2158591358 @default.
• W2906750861 cites W2159763561 @default.
• W2906750861 cites W2161681729 @default.
• W2906750861 cites W2168640113 @default.
• W2906750861 cites W2171083652 @default.
• W2906750861 cites W2184533840 @default.
• W2906750861 cites W2273842183 @default.
• W2906750861 cites W2324016220 @default.
• W2906750861 cites W2340662778 @default.
• W2906750861 cites W2370339191 @default.
• W2906750861 cites W2397385450 @default.
• W2906750861 cites W2406928924 @default.
• W2906750861 cites W2528652129 @default.
• W2906750861 cites W2529744408 @default.
• W2906750861 cites W2556899316 @default.
• W2906750861 cites W2596845796 @default.
• W2906750861 cites W2605696265 @default.
• W2906750861 cites W2607023284 @default.
• W2906750861 cites W2620241325 @default.
• W2906750861 cites W2735344772 @default.
• W2906750861 cites W2737868829 @default.
• W2906750861 cites W2738956768 @default.
• W2906750861 cites W2757073890 @default.
• W2906750861 cites W2769445535 @default.
• W2906750861 cites W2804596530 @default.
• W2906750861 cites W2805758850 @default.
• W2906750861 cites W3020992950 @default.
• W2906750861 cites W4237939525 @default.
• W2906750861 cites W4246611736 @default.
• W2906750861 doi "https://doi.org/10.1016/j.actbio.2018.12.046" @default.
• W2906750861 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30597258" @default.
• W2906750861 hasPublicationYear "2019" @default.
• W2906750861 type Work @default.
• W2906750861 sameAs 2906750861 @default.
• W2906750861 citedByCount "39" @default.
• W2906750861 countsByYear W29067508612019 @default.
• W2906750861 countsByYear W29067508612020 @default.
• W2906750861 countsByYear W29067508612021 @default.
• W2906750861 countsByYear W29067508612022 @default.
• W2906750861 countsByYear W29067508612023 @default.
• W2906750861 crossrefType "journal-article" @default.
• W2906750861 hasAuthorship W2906750861A5003576716 @default.

• next